Medical Services VScan HIV Test Kit Receives Approval in China
EDMONTON, Alberta -- Medical Services International Inc. is pleased to announce that it has received full regulatory approval to sell its VScan HIV 1&2 rapid test kits in the Peoples Republic of China. With the regulatory approval, the company will now begin processing the existing orders for the VScan HIV test kit that have an approximate value of $4,600,000 U.S. These are initial orders and it is anticipated that additional orders will follow immediately. The distribution network that has been established will begin its marketing program as quickly as it can be implemented. The kits will be manufactured in the companys new Shanghai facility. The company has agreed that the Shanghai facility will be the supplier for all of Southeast Asia.
With the regulatory approvals in China, India and Nigeria, plus other approvals that have been obtained in other countries, the VScan HIV1&2 rapid test kit is now approved for all levels including retail in countries representing approximately 40 percent of the world population. These approvals are in countries that represent a significant proportion of the population worldwide that have severe HIV/AIDS problems.
Source: Medical Services International Inc.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
